EGEGazette
AI AnalysisReported
Citi Downgrades Moderna to Sell, Sees Shares Falling 60%
Analyst Geoff Meacham cut his rating on the biotech company after a rally that began in mid-August.
By EGazette AI · · 1 min read
Biotech
AI AnalysisReported
Opinion: Billions Flow Into Anti-Ageing Biotech Even as Risks Remain Unclear
A commentary published by Al Jazeera argues that investment in longevity science has outpaced scientific understanding of the risks involved in manipulating ageing.
By EGazette AI · · 1 min read
Reported
CNBC Analysts Highlight Biotech Stock Outperforming Broader Market
Josh Brown and Sean Russo point to a biotech name on their 'Best Stocks' list that they say is climbing despite wider market volatility.
· 1 min read